Ashwagandha: what the evidence actually shows

Ashwagandha (Withania somnifera) modestly reduces perceived stress and cortisol in chronically stressed lifters, providing minor secondary benefits for recovery and endurance. It is not an anabolic agent. Take 300 to 600 mg of standardized root extract daily.

In the fitness industry, adaptogens are routinely marketed as near-miraculous botanical compounds capable of simultaneously erasing adrenal fatigue, melting visceral fat, and sending endogenous testosterone levels through the roof. Most of these claims collapse the moment you pull the primary literature. Ashwagandha (Withania somnifera), an evergreen shrub with centuries of traditional use in Ayurvedic medicine, is currently the most popular of these botanicals.

When trainees come to us asking whether they should add ashwagandha to their daily stack, they are usually looking for a pharmacological shortcut around high life stress, poor sleep hygiene, or excessive training volume. My role as an exercise physiologist is to separate physiological mechanism from marketing exaggeration. We do not guess, and we do not accept promotional claims from supplement distributors. We examine randomized human trials, evaluate statistical effect sizes, and establish whether an intervention produces meaningful real-world adaptations.

Let us examine the bioactive chemistry of Withania somnifera, analyze the clinical evidence on stress, cognition, and exercise performance, define its genuine limitations, and outline a practical dosing strategy.

Botanical Chemistry and Pharmacological Mechanisms

The therapeutic properties of Withania somnifera root are primarily attributed to a class of naturally occurring steroidal lactones known as withanolides, most notably withaferin A and withanolide A, along with various alkaloids and sitoindosides.

In human physiology, chronic psychological or physiological stress stimulates the hypothalamic-pituitary-adrenal (HPA) axis. The hypothalamus secretes corticotropin-releasing hormone (CRH), which prompts the anterior pituitary to release adrenocorticotropic hormone (ACTH), ultimately triggering the adrenal cortex to produce cortisol. While acute cortisol elevation is an essential survival response and a natural byproduct of intense resistance training, chronically elevated basal cortisol drives skeletal muscle protein breakdown, impairs sleep architecture, suppresses immune function, and disrupts autonomic recovery.

The primary bioactive mechanisms of standardized ashwagandha extract involve:

1. HPA Axis Attenuation: Withanolides appear to downregulate excessive CRH and ACTH signaling in individuals undergoing sustained stress, leading to measurable reductions in circulating serum and salivary cortisol concentrations.
2. GABAergic Neurotransmission Modulation: Ashwagandha demonstrates gamma-aminobutyric acid (GABA)-mimetic activity. By binding to or modulating GABA-A receptors in the central nervous system, withanolide constituents promote inhibitory neural signaling, reducing sympathetic nervous system hyperarousal, subjective anxiety, and somatic tension.
3. Antioxidant and Mitochondrial Support: Bioactive withanolides upregulate endogenous antioxidant enzymes—such as superoxide dismutase (SOD) and catalase—mitigating excessive reactive oxygen species (ROS) production in neural and muscular tissues under metabolic stress.

These physiological actions explain why ashwagandha functions predominantly as a mild calming agent and adaptogen rather than an aggressive ergogenic stimulant.

Neuropsychiatric and Clinical Evidence: The D'Cruz et al. Systematic Review

To evaluate the broader clinical validity of Withania somnifera, D'Cruz and Andrade (PMID 36062480) conducted a comprehensive review titled "Potential clinical applications of Ashwagandha (Withania somnifera) in medicine and neuropsychiatry" published in Expert Review of Clinical Pharmacology.

D'Cruz and Andrade systematically evaluated the peer-reviewed evidence across several clinical categories, including generalized stress, anxiety disorders, sleep disturbances, cognitive decline, and metabolic markers. Their review established several critical findings:

• Stress and Anxiety Reductions: Across multiple double-blind, placebo-controlled human trials, standardized ashwagandha extracts consistently outperformed placebo in reducing scores on validated psychiatric instruments, including the Perceived Stress Scale (PSS) and the Hamilton Anxiety Rating Scale (HAM-A).
• Endocrine Markers: The clinical data analyzed by D'Cruz and Andrade confirmed statistically significant reductions in morning serum cortisol levels among chronically stressed cohorts, typically ranging between 15 and 30 percent reductions relative to baseline.
• Sleep Quality Improvements: Participants reporting mild insomnia or disturbed sleep demonstrated improved sleep latency (the time required to fall asleep) and sleep efficiency, largely driven by GABA-mediated central nervous system relaxation.
• Methodological Nuance: D'Cruz and Andrade noted that while the therapeutic potential of Withania somnifera is supported by clinical trials, many individual studies suffer from modest sample sizes, varying extract standardizations, and relatively short trial durations (ranging from 6 to 12 weeks).

The review by D'Cruz and Andrade demonstrates that ashwagandha possesses genuine anxiolytic and cortisol-modulating properties, but it emphasizes that it functions as a supportive clinical intervention rather than a standalone medical cure.

Cognitive Function and Mood: The Clinical Trial by Leonard et al.

Beyond general stress reduction, how does ashwagandha supplementation influence acute cognitive performance, mental clarity, and mood states during demanding tasks?

This question was directly investigated by Leonard and colleagues (PMID 38931168) in a randomized, double-blind, placebo-controlled trial published in Nutrients titled "Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood."

Leonard and co-authors evaluated the effects of both single-dose (acute) and sustained 30-day (repeated) supplementation with a standardized Withania somnifera extract in healthy men and women. The investigators assessed psychomotor speed, executive function, sustained attention, and subjective mood scales.

The trial conducted by Leonard and colleagues yielded several relevant outcomes:

• Sustained Attention and Working Memory: Participants receiving the standardized extract demonstrated measurable improvements in cognitive processing speed and sustained attention during complex psychometric testing batteries compared to the placebo group.
• Acute vs. Chronic Adaptations: While a single acute dose produced minor improvements in subjective alertness, repeated daily administration over 30 days yielded more pronounced improvements in cognitive stability and mental fatigue resistance.
• Mood Profile Stabilization: Leonard and colleagues observed significant reductions in self-reported feelings of tension, confusion, and cognitive fatigue following sustained supplementation.

These findings from Leonard and colleagues suggest that ashwagandha can help buffer the cognitive decrements and mental fog that typically accompany sustained psychological workloads and demanding training blocks.

Exercise Endurance and Cardiorespiratory Capacity: The Prajapati et al. Trial

A growing area of athletic interest is whether ashwagandha enhances physical performance and cardiorespiratory endurance in active populations.

This was rigorously examined by Prajapati and colleagues (PMID 41846233) in a randomized, placebo-controlled, double-blind clinical trial titled "Efficacy and Safety of Low-Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial" published in Phytotherapy Research.

Prajapati and co-authors investigated the impact of low-dose standardized ashwagandha supplementation over an extended intervention period in active human subjects. The investigators measured maximal oxygen consumption (VO2 max), time to exhaustion during graded exercise testing, exercise-induced fatigue indices, and comprehensive safety parameters.

The trial by Prajapati and colleagues demonstrated notable performance outcomes:

• Cardiorespiratory Endurance (VO2 Max): Subjects supplementing with low-dose standardized ashwagandha achieved statistically significant improvements in VO2 max compared to the placebo cohort, indicating enhanced oxygen uptake and utilization kinetics during maximal exertion.
• Prolonged Time to Exhaustion: The active group exhibited increased time to exhaustion during high-intensity endurance testing, suggesting reduced perceived exertion and improved cellular energetic efficiency under sustained metabolic demand.
• Safety and Tolerability: Prajapati and colleagues recorded normal hematological, hepatic, and renal safety panels throughout the study duration, confirming the safety profile of low-dose standardized administration in healthy adults.

The work of Prajapati and colleagues indicates that ashwagandha may offer a small, reproducible ergogenic advantage for endurance capacity, likely mediated through a combination of enhanced mitochondrial efficiency, improved oxygen transport dynamics, and attenuated central fatigue.

What Ashwagandha Does NOT Do: Dismantling the Hype

To evaluate ashwagandha objectively, we must strip away the unsubstantiated marketing narratives that dominate social media and retail supplement stores.

1. It Is Not an Anabolic Steroid or Primary Muscle Builder

You will frequently see advertisements claiming ashwagandha is a natural muscle builder that skyrockets testosterone. While a few isolated studies in untrained or highly stressed men have noted slight increases in total testosterone (typically 10 to 15 percent), this is an indirect byproduct of reducing high baseline cortisol, not direct androgenic stimulation. In healthy, well-nourished lifters with normal baseline endocrine function, ashwagandha will not produce meaningful changes in free testosterone or directly stimulate myofibrillar protein synthesis.

2. It Does Not Replace Sleep, Recovery, or Intelligent Programming

Taking 600 mg of ashwagandha root extract will not offset the systemic damage of sleeping five hours per night, drinking excessive alcohol, or maintaining an unsustainable weekly training volume. Adaptogens do not eliminate biological fatigue; they merely modulate stress perception. If your lifestyle fundamentals are broken, no botanical root will rescue your performance.

Before considering adaptogens, review our guide to a supplements foundation first approach to ensure that your total daily energy intake, macronutrient distribution, sleep hygiene, and training density are fully dialed in.

3. It Does Not Burn Body Fat or Accelerate Metabolic Rate

Ashwagandha is not a thermogenic agent. It contains no sympathomimetic compounds like caffeine, synephrine, or yohimbine. Any fat loss reported in clinical trials involving stressed cohorts is mediated by reduced stress-induced emotional eating and improved sleep quality, not direct lipolysis. Energy balance remains the non-negotiable determinant of fat loss.

For a rigorous evaluation of which sports supplements actually justify your investment versus those that rely on marketing hype, examine our breakdown of evidence-based supplements versus marketing hype and our curated supplement collection guidelines.

Safety, Tolerability, and Adverse Effect Profile

While standardized Withania somnifera extracts exhibit a favorable safety profile in the published literature, it is not free of potential side effects and contraindications.

1. Gastrointestinal Discomfort: Mild nausea, diarrhea, or upset stomach can occur, particularly when taking high doses on an empty stomach. Consuming the supplement with food easily resolves this issue.
2. Thyroid Hormone Modulation: Ashwagandha can mildly stimulate the thyroid gland, increasing circulating levels of thyroxine (T4) and triiodothyronine (T3). Individuals diagnosed with hyperthyroidism or Graves' disease must avoid ashwagandha, and anyone taking exogenous thyroid medication should exercise caution.
3. Sedation and Lethargy: Because of its GABA-mimetic activity, some individuals experience daytime grogginess or an unwanted blunting of emotional arousal (emotional flattening) when taking high doses or using it during daytime hours.
4. Idiosyncratic Liver Concerns: Extremely rare case reports of acute, reversible drug-induced liver injury have been reported in international medical databases, typically associated with non-standardized proprietary blends, multi-ingredient formulations, or contaminated botanical raw materials. Purchasing verified, third-party tested standardized extracts is essential.

Dosing Protocol and Extract Selection

When selecting an ashwagandha product, raw unstandardized root powder is inefficient due to wild variability in active withanolide concentrations. You must look for standardized root extracts that clearly state their withanolide content on the label.

1. Extract Standardization

Look for standardized root extracts such as KSM-66 (standardized to 5% withanolides) or Sensoril (standardized to 10% withanolides). These extracts are produced via standardized extraction procedures that guarantee chemical consistency across batches.

2. Daily Dosing

• Standardized Root Extract (e.g., KSM-66): 300 to 600 mg per day, taken in a single dose or split into two 300 mg doses.
• High-Concentration Extract (e.g., Sensoril): 125 to 250 mg once or twice daily.

3. Timing of Ingestion

Because ashwagandha modulates GABAergic pathways and promotes relaxation, most trainees benefit from taking their daily dose with dinner or roughly 30 to 60 minutes before bed. This timing optimizes sleep latency while preventing daytime sluggishness.

4. Duration and Cycling

Given that the vast majority of clinical trials evaluate periods of 8 to 12 weeks, a prudent protocol is to use ashwagandha during periods of acute lifestyle or training stress (such as a rigorous training block, a caloric deficit, or a high-workload professional phase) for 8 to 12 weeks, followed by a 2 to 4-week washout period.

What the Evidence Does Not Support

A rigorous scientific appraisal requires highlighting where current literature is incomplete:

• The evidence does not support indefinite, year-round usage: Long-term safety data beyond six months of continuous daily use is limited. Cycling off periodically remains the most sensible approach.
• The evidence does not support acute pre-workout performance boosts: Unlike caffeine or beta-alanine, ashwagandha does not provide an immediate surge in force production or central drive when taken 30 minutes before stepping under a barbell.
• The evidence does not support direct hypertrophy enhancement in trained lifters: Any observed hypertrophic benefit in studies is secondary to improved recovery and training consistency in stressed populations, not direct intracellular signaling through the mTOR pathway.

If your training progress has plateaued, buying more supplements will not correct fundamental programming flaws. At Titan Forge, our one-on-one coaching programs focus on the real drivers of physical development: individualized volume benchmarks, progressive overload management, and nutritional precision. Titan Forge is where you go when you are ready to take yourself seriously.

Monday Morning Implementation Protocol

If you choose to incorporate ashwagandha into your routine, follow this protocol:

1. Audit your recovery fundamentals first: Confirm that you are averaging at least 7 to 9 hours of quality sleep, hitting your daily protein target, and managing total training stress before purchasing any adaptogen.
2. Select a standardized extract: Purchase a standalone product standardized to 5% withanolides (such as KSM-66) from a third-party tested brand. Avoid multi-ingredient proprietary blends.
3. Dose 300 to 600 mg daily with food: Take your dose with your evening meal or 45 minutes prior to sleep to support nighttime relaxation and minimize gastrointestinal irritation.
4. Use for defined 8 to 12-week cycles: Deploy the supplement during intense training blocks or phases of elevated work stress, followed by a 2 to 4-week break.
5. Track objective recovery metrics: Monitor resting heart rate, sleep quality, and gym performance in your training log to evaluate whether the compound delivers a tangible return on investment.

---

FAQ

How long does it take for ashwagandha to start working?

In our coaching practice, clients often expect overnight results, but meaningful adaptogenic shifts require cumulative dosing. While acute calming effects can occur within hours due to GABA-A receptor modulation, measurable reductions in resting cortisol and perceived stress typically take two to four weeks of consistent daily intake. If you do not notice changes in your recovery markers or subjective tension by week four, continuing the same protocol is unlikely to yield sudden benefits.

Will ashwagandha make me feel emotionally numb or unmotivated?

Emotional blunting or anhedonia is one of the most common complaints we hear from lifters using high doses continuously. Because bioactive withanolides enhance inhibitory GABAergic signaling and suppress cortisol, excessive or prolonged suppression can dampen emotional arousal, drive, and training aggression. If you begin feeling indifferent or flat in the gym, drop your daily dose immediately or begin a two-week washout phase.

Can I take ashwagandha with my morning pre-workout or caffeine?

we do not recommend combining ashwagandha directly with high-stimulant pre-workouts. Caffeine acts as an adenosine antagonist and central nervous system stimulant, whereas withanolides promote inhibitory GABAergic signaling, meaning the two compounds work in direct pharmacological opposition. If you prefer morning dosing, separate your adaptogen from your pre-workout by several hours to avoid blunting the ergogenic drive needed for heavy lifting.

Should I take ashwagandha on rest days?

Yes, you should maintain your daily dose on non-training days without interruption. Adaptogenic compounds rely on steady tissue saturation and chronic modulation of the HPA axis rather than acute timing around training sessions. Taking your standard dose with your evening meal on rest days maintains circulating withanolide concentrations and supports parasympathetic recovery when systemic repair is highest.